Kui Cheng

4.2k total citations
92 papers, 3.3k citations indexed

About

Kui Cheng is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Kui Cheng has authored 92 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Immunology, 24 papers in Molecular Biology and 13 papers in Oncology. Recurrent topics in Kui Cheng's work include Immune Response and Inflammation (26 papers), Nanoplatforms for cancer theranostics (10 papers) and NF-κB Signaling Pathways (9 papers). Kui Cheng is often cited by papers focused on Immune Response and Inflammation (26 papers), Nanoplatforms for cancer theranostics (10 papers) and NF-κB Signaling Pathways (9 papers). Kui Cheng collaborates with scholars based in China, United States and Norway. Kui Cheng's co-authors include Hang Yin, Xiaohui Wang, John B. Schenkman, Xiaohong Cen, Shuwen Liu, Kutty Selva Nandakumar, Marilyn Khanna, Bernard Moss, Kenan Qin and Shuting Zhang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Kui Cheng

85 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kui Cheng China 31 1.1k 856 392 358 350 92 3.3k
Tomoko Kita Japan 36 1.2k 1.1× 410 0.5× 339 0.9× 286 0.8× 365 1.0× 131 4.2k
Alexandra K. Kiemer Germany 42 2.0k 1.8× 834 1.0× 363 0.9× 304 0.8× 99 0.3× 137 4.6k
Takashi Izumi Japan 39 2.4k 2.2× 690 0.8× 242 0.6× 427 1.2× 134 0.4× 150 4.7k
Shobha Ghosh United States 33 1.7k 1.5× 540 0.6× 236 0.6× 421 1.2× 122 0.3× 100 3.8k
Marta Menegazzi Italy 37 1.4k 1.3× 536 0.6× 254 0.6× 654 1.8× 209 0.6× 104 3.6k
Pamela T. Manning United States 37 1.8k 1.7× 995 1.2× 336 0.9× 468 1.3× 287 0.8× 67 6.9k
Do‐Hee Kim South Korea 41 2.2k 2.0× 369 0.4× 222 0.6× 593 1.7× 136 0.4× 181 4.5k
Betty Yuen Kwan Law Macao 38 2.3k 2.1× 374 0.4× 275 0.7× 358 1.0× 294 0.8× 130 4.2k
Angela Ianaro Italy 41 1.7k 1.6× 899 1.1× 226 0.6× 382 1.1× 87 0.2× 121 5.1k
Madhu Dikshit India 39 1.5k 1.4× 1.6k 1.9× 206 0.5× 151 0.4× 348 1.0× 192 5.1k

Countries citing papers authored by Kui Cheng

Since Specialization
Citations

This map shows the geographic impact of Kui Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kui Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kui Cheng more than expected).

Fields of papers citing papers by Kui Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kui Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kui Cheng. The network helps show where Kui Cheng may publish in the future.

Co-authorship network of co-authors of Kui Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Kui Cheng. A scholar is included among the top collaborators of Kui Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kui Cheng. Kui Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Jie, Xianbo Xiang, Jia Wei, et al.. (2025). A cleavage-gated terminal exposure-driven CRISPR-RCA self-amplifying system for ultra-fast DNA detection. Biosensors and Bioelectronics. 289. 117857–117857.
2.
Qiao, Hui, Y.X. Leng, Sumei Huang, et al.. (2025). Insight into the synergistic fixation and reduction of Cr(VI) by artificial humic acid-montmorillonite coprecipitates. Colloids and Surfaces A Physicochemical and Engineering Aspects. 727. 138458–138458.
3.
4.
Bai, Lu, et al.. (2024). Comparative study of [18F]AlF-PAI-PDL1p and [68Ga]Ga-PAI-PDL1p as novel PD-L1 targeting PET probes for tumor imaging. Bioorganic Chemistry. 151. 107660–107660. 2 indexed citations
5.
Xie, Lin, et al.. (2024). Design, synthesis and anti-tumor evaluation of novel pyrimidine and quinazoline analogues. European Journal of Medicinal Chemistry. 282. 117057–117057. 5 indexed citations
6.
Liu, Shi, et al.. (2024). Pretheranostic agents with extraordinaryNIRF/photoacoustic imaging performanceand photothermal oncotherapy efficacy. Acta Pharmaceutica Sinica B. 14(12). 5370–5381. 2 indexed citations
7.
Yang, Shuo, Jiesi Luo, Kui Cheng, et al.. (2024). Oxymatrine, a novel TLR2 agonist, promotes megakaryopoiesis and thrombopoiesis through the STING/NF-κB pathway. Journal of Pharmaceutical Analysis. 15(1). 101054–101054.
8.
Yang, Junjie, Yue Pan, Xiaoshan Zeng, et al.. (2023). Discovery of novel aporphine alkaloid derivative as potent TLR2 antagonist reversing macrophage polarization and neutrophil infiltration against acute inflammation. Acta Pharmaceutica Sinica B. 13(9). 3782–3801. 13 indexed citations
9.
Liang, Yuqing, Kutty Selva Nandakumar, & Kui Cheng. (2020). Design and pharmaceutical applications of proteolysis-targeting chimeric molecules. Biochemical Pharmacology. 182. 114211–114211. 14 indexed citations
10.
Zheng, Lu, et al.. (2020). Potential treatment methods targeting 2019-nCoV infection. European Journal of Medicinal Chemistry. 205. 112687–112687. 34 indexed citations
11.
Cen, Xiaohong, Junjie Yang, Jianjun Yang, et al.. (2019). TLR1/2 Specific Small‐Molecule Agonist Suppresses Leukemia Cancer Cell Growth by Stimulating Cytotoxic T Lymphocytes. Advanced Science. 6(10). 49 indexed citations
12.
Wang, Wenqing, et al.. (2019). Structure-activity relationship study and biological evaluation of SAC-Garlic acid conjugates as novel anti-inflammatory agents. European Journal of Medicinal Chemistry. 179. 233–245. 13 indexed citations
13.
Gao, Meng, Nir London, Kui Cheng, et al.. (2014). Rationally designed macrocyclic peptides as synergistic agonists of LPS-induced inflammatory response. Tetrahedron. 70(42). 7664–7668. 16 indexed citations
14.
Li, Cheng, Tongtong Liu, Lisa Broske, et al.. (2008). Permeability evaluation of peptidic HCV protease inhibitors in Caco-2 cells-correlation with in vivo absorption predicted in humans. Biochemical Pharmacology. 76(12). 1757–1764. 10 indexed citations
15.
Wang, Wei, Jing Chen, S. Shane Taremi, et al.. (2008). Construction and characterization of a fully active PXR/SRC-1 tethered protein with increased stability. Protein Engineering Design and Selection. 21(7). 425–433. 49 indexed citations
16.
Li, Cheng, Latha G. Nair, Fangbiao Li, et al.. (2007). Correlation between PAMPA permeability and cellular activities of hepatitis C virus protease inhibitors. Biochemical Pharmacology. 75(5). 1186–1197. 24 indexed citations
17.
Xiao, Li, Xiaoming Cui, Vincent Madison, Ronald E. White, & Kui Cheng. (2002). Insights from a Three-Dimensional Model into Ligand Binding to Constitutive Active Receptor. Drug Metabolism and Disposition. 30(9). 951–956. 28 indexed citations
18.
Khanna, Marilyn, Kenan Qin, Regina W. Wang, & Kui Cheng. (1995). Substrate Specificity, Gene Structure, and Tissue-specific Distribution of Multiple Human 3α-Hydroxysteroid Dehydrogenases. Journal of Biological Chemistry. 270(34). 20162–20168. 161 indexed citations
19.
Cheng, Kui, Julie Lee, Marilyn Khanna, & Kenan Qin. (1994). Distribution and ontogeny of 3α-hydroxysteroid dehydrogenase in the rat brain. The Journal of Steroid Biochemistry and Molecular Biology. 50(1-2). 85–89. 21 indexed citations
20.
Cheng, Kui, James M. Groarke, Babatunde Osotimehin, Howard C. Haspel, & Martin Sonenberg. (1981). Effects of insulin, catecholamines, and cyclic nucleotides on rat adipocyte membrane potential.. Journal of Biological Chemistry. 256(2). 649–655. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tomoko Kita Breakdown of academic impact, for papers by Alexandra K. Kiemer Breakdown of academic impact, for papers by Takashi Izumi Breakdown of academic impact, for papers by Shobha Ghosh Breakdown of academic impact, for papers by Marta Menegazzi Breakdown of academic impact, for papers by Pamela T. Manning Breakdown of academic impact, for papers by Do‐Hee Kim Breakdown of academic impact, for papers by Betty Yuen Kwan Law Breakdown of academic impact, for papers by Angela Ianaro Breakdown of academic impact, for papers by Madhu Dikshit
Rankless by CCL
2026